The Use of Transdermal Scopolamine in the Control of Death Rattle

Abstract

View all access options for this article.

Clissold

S.P.

, Heel

R.C.

Transdermal hyoscine (scopolamine): A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Drug 1985; 29: 189–207.

Compendium of pharmaceuticals and specialities 1988. Krogh

, ed., 23rd edition. Ottawa: Canadian Pharmaceutical Association 1988.

Copperman

Topics in community health: dying at home. Chichester: John Wiley & Sons 1983.

Dahl

, Offer-Ohlsen

Transdermal scopolamine, oral meclizine, and placebo in motion sickness.

Clin Pharmacol Ther 1984; 36: 116–9.

Dawson

Palliative care in the home: a teaching hospital model.

Canadian Family Physician 1988; 33: 2771–77.

Rogawski

Transdermal scopolamine and sialorrhea.

Arch Neurol (Letter to the editor) 1984.

van Marion

W.F.

, Bongaerts

M.C.M.

Influence of transdermal scopolamine on motion sickness during 7 day's exposure to heavy seas.

Clin Pharmacol Ther 1985; 38: 301–5.